Pfizer Inc  $40.39

Pfizer Inc. is a global biopharmaceutical company focused on research and development. The company is headquartered in New York City, New York and has 79,000 full-time employees. Pfizer is engaged in the discovery, development, manufacture, marketing, sale, and distribution of biopharmaceutical products worldwide. It operates through two segments, Biopharma and PC1. The Biopharma segment comprises six therapeutic areas, including Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. The PC1 segment is a global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Pfizer's products, such as Comirnaty/BNT162b2, Ibrance, and Eliquis, have been successful in the market, resulting in a high market cap and stock price today. Keep an eye on Pfizer's premarket movements as their shares are often in high demand.